Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biochimica Et Biophysica Acta|June 4, 2014
Immunogen design for HIV-1 and influenzaUjjwal Rathore, Sannula Kesavardhana, V Vamsee Aditya Mallajosyula, et al.
The Journal of Biological Chemistry|June 19, 2010
Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodiesSanchari Bhattacharyya, Roshan Elizabeth Rajan, Yalla Swarupa, et al.
The Journal of Biological Chemistry|April 28, 2017
Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivityUjjwal Rathore, Piyali Saha, Sannula Kesavardhana, et al.
The Journal of Biological Chemistry|February 23, 2013
Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodiesSanchari Bhattacharyya, Pranveer Singh, Ujjwal Rathore, et al.
The Journal of Biological Chemistry|August 11, 2018
Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodiesUjjwal Rathore, Mansi Purwar, Venkada Subramanian Vignesh, et al.
Mbio|February 27, 2024
CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cellsUjjwal Rathore, Paige Haas, Vigneshwari Easwar Kumar, et al.
Nature Communications|April 2, 2022
A functional map of HIV-host interactions in primary human T cellsJoseph Hiatt, Judd F Hultquist, Michael J McGregor, et al.
Iscience|June 17, 2026
Paracrine signals from HIV-1-infected immune cells reprogram cervical cancer pathwaysCharles Ochieng' Olwal, Ujjwal Rathore, Sara K Makanani, et al.
Cell Reports|May 12, 2021
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteinsJoseph Hiatt, Devin A Cavero, Michael J McGregor, et al.
Pageof 2